Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

CLL Monthly Minutes

Using Telemedicine to Protect Vulnerable Patients and Provide Access to Care During COVID-19
The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay. Read More ›

Studying the Effects of a “Can-Do” Attitude on Cancer Outcomes
Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights. Read More ›

Lenalidomide Maintenance Therapy Linked to B-Cell Acute Lymphoblastic Leukemia
Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study. Read More ›

A Look at COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia
It is recommended that most patients with CLL receive the COVID-19 vaccine, although each patient should still talk with their healthcare team first. Read More ›

Predicting Which Patients with Chronic Lymphocytic Leukemia Might Need Early Treatment
A new laboratory-based scoring system may allow physicians to better predict which patients with early-stage CLL are most likely to require early treatment. Read More ›

Evaluating the Risk of Severe COVID-19 in Patients with Chronic Lymphocytic Leukemia
Patients with CLL may be at increased risk for developing severe COVID-19. Experts have provided insights on how to protect them while still delivering optimal care. Read More ›

Zanubrutinib Now Recommended for Certain Patients with Chronic Lymphocytic Leukemia
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients. Read More ›

A Look at Cannabis Extracts for Patients with Chronic Lymphocytic Leukemia
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know? Read More ›

Moving Toward a Better Understanding of the Chronic Lymphocytic Leukemia Patient Experience
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience. Read More ›

Watchful Waiting with Chronic Lymphocytic Leukemia
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider. Read More ›

Page 3 of 5